Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible reason why.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. appointed a new chair and 10 new public members to the Advisory Council on Alzheimer's Research, Care, and Services, the department said ...

Shifting care needs in Rockwall highlight the growing importance of understanding memory care versus independent and ...

Researchers connecting pieces of the massive Alzheimer's puzzle are closer to slotting the next one in place, with yet ...

People often worry they will get Alzheimer’s disease if their parents did. But engaging in a healthy lifestyle can outweigh ...

Alzheimer's disease has long been thought to be irreversible, but new research using a mouse model offers hope.

Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

Researchers have found that a natural aging-related molecule can repair key memory processes affected by Alzheimer’s disease.

The study found that by using this ultrasound technology on test mice, a 75% memory function was fully restored.

The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...

Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.